Meeting
2021 ASCO Annual Meeting
Intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD).
Authors
Ida John
The University of Texas MD Anderson Cancer Center, Houston, TX
Ida John , Alexandra P. Foster , Cara L. Haymaker , Roland L. Bassett Jr., J. Jack Lee , Michelle L. Rohlfs , Jessie Richard , Masood Iqbal , Ian E. McCutcheon , Sherise D. Ferguson , Amy B. Heimberger , Chantal M Saberian , Barbara Jane O'Brien , Sudhakar Tummala , Nandita Guha- Thakurta , Matthew Debnam , Hussein Abdul-Hassan Tawbi , Elizabeth M. Burton , Michael A. Davies , Isabella Claudia Glitza
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT03025256
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9519)
DOI
10.1200/JCO.2021.39.15_suppl.9519
Abstract #
9519
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Safety and preliminary efficacy of intrathecal (IT) and intravenous (IV) nivolumab (N) for patients (pts) with leptomeningeal disease (LMD).
First Author: Isabella Claudia Glitza
Poster
2023 ASCO Annual Meeting
Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N).
First Author: Golnaz Morad
Poster
2021 ASCO Annual Meeting
Trial in progress: Phase I/II study of radiation therapy followed by intrathecal trastuzumab/pertuzumab in the management of HER2+ breast leptomeningeal disease.
First Author: Kamran A. Ahmed
Poster
2024 ASCO Annual Meeting
Efficacy of intrathecal delivery of peptide-pulsed type 1 conventional dendritic cell vaccine for the treatment of breast cancer-associated leptomeningeal disease in preclinical models.
First Author: Vincent Law